USFDA nod for Orchid Chemicals anti-bacterial drug

USFDA nod for Orchid Chemicals anti-bacterial drug

Mumbai: Orchid Chemicals and Pharmaceuticals Friday said it has received USFDA approval for multiple strengths of Cefpodoxime Proxetil tablets, which are used to treat a variety of bacterial infections.

The company received the approval for its Abbreviated New Drug Application (ANDA) for Cefpodoxime Proxetil tablets, in dosages of 100 mg and 200 mg, Orchid Chemicals said in a filing to the Bombay Stock Exchange.

With limited generic competition in this product, the company hopes to garner a sizable market share and revenues in the US market, the company added.

Cefpodoxime Proxetil is a third generation cephalosporin antibiotic which has a broad spectrum activity against organisms causing infectious diseases.